Forbes Tech A New Antibody Treatment For Breast Cancer
A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve damage and hair loss than standard chemotherapy.
A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve damage and hair loss than standard chemotherapy.